Browsing by Author "Celenk, B"
Now showing 1 - 7 of 7
Results Per Page
Sort Options
Item Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapyKilinc, O; Soylar, O; Cilli, A; Sakar, A; Tasbakan, S; Ellidokuz, H; Celenk, B; Cetinkaya, C; Gunduz, C; Sayiner, AItem A new scoring system to predict mortality in community-acquired pneumonia: CURB (S)-65Bahçecioglu, SN; Köktürk, N; Baha, A; Yapar, D; Aksakal, FNB; Gunduz, C; Tasbakan, S; Sayiner, A; Coskun, AS; Yaman, F; Çilli, A; Celenk, B; Kilinç, O; Mersin, SS; Hazar, A; Tokgoz, FOBJECTIVE: The first decision to be made in the case of community-acquired pneumonia (CAP) is whether hospitalization of the patient is mandatory. In this study, we aimed to investigate whether the addition of oxygenation parameters to CURB-65 has diagnostic value in predicting mortality in CAP. PATIENTS AND METHODS: A total of 903 CAP patients were included in the study. Patients with a CURB-65 score of 0 and 1 were classified as Group 1 and patients with a CURB-65 score of 2 or more were classified as Group 2. The prediction of mortality through Pneumonia Severity Index (PSI), CURB-65 and CURBS-65/CURBP- 65 with the addition of SaO(2) and PaO2 values; hence the four different models, was compared among all patient groups. RESULTS: As a result, 3.3% of the cases in Group 1 and 12.7% of the cases in Group 2 died. In both CURB-65 groups, it was noted that the frequency of patients with SaO(2) <90% was significantly higher in the dead group than in the alive patient group (p= 0.009 and p= 0.001, respectively). In the univariate analysis, PaO2<60, and SaO(2)<90 were significantly associated with mortality. Model 2 (CURBS-65) and Model 3 (CURBP-65) were examined, SaO(2)< 90 (OR 2.08) was found to have an effect on death. In predicting mortality by the receiver operating characteristics (ROC) analysis, it was understood that the CURBS-65 score had a slightly higher area under the curve (AUC) value than CURB-65. CONCLUSIONS: As a result, it has been shown that the use of CURBS-65 scoring instead of CURB-65 clinical scoring may be more useful in predicting mortality.Item Prognosis of hospitalized patients with community-acquired pneumoniaAkyil, FT; Yalcinsoy, M; Hazar, A; Cilli, A; Celenk, B; Kilic, O; Sayiner, A; Kokturk, N; Coskun, AS; Filiz, A; Edis, ECIntroduction: The long-term prognosis of patients with community-acquired pneumonia (CAP) has attracted increasing interest in recent years. The objective of the present study is to investigate the short and long-term outcomes in hospitalized patients with CAP and to identify the predictive factors associated with mortality. Patients and methods: The study was designed as a retrospective, multicenter, observational study. Hospitalized patients with CAP, as recorded in the pneumonia database of the Turkish Thoracic Society between 2011 and 2013, were included. Short-term mortality was defined as 30-day mortality and long-term mortality was assessed from those who survived 30 days. Predictive factors for short- and long-term mortality were analyzed. Results: The study included 785 patients, 68% of whom were male and the mean age was 67 +/- 16 (18-92). The median duration of follow-up was 61.2 +/- 11.8 (37-90) months. Thirty-day mortality was 9.2% and the median survival of patients surviving 30 days was 62.8 +/- 4.4 months. Multivariate analysis revealed that advanced age, the absence of fever, a higher Charlson comorbidity score, higher blood urea nitrogen (BUN)/albumin ratios and lower alanine aminotransferase (ALT) levels were all predictors of long-term mortality. Conclusion: Long-term mortality following hospitalization for CAP is high. Charlson score and lack of fever are potential indicators for decreased long-term survival. As novel parameters, baseline BUN/albumin ratios and ALT levels are significantly associated with late mortality. Further interventions and closer monitoring are necessary for such subgroups of patients. (C) 2017 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U.Item The effect of inhaled corticosteroids in the outcomes of community-acquired pneumonia: ICCAP study (TURKCAP Database)Baha, A; Kokturk, N; Bahcecioglu, SN; Yapar, D; Aksakal, N; Gündüz, C; Tasbakan, S; Sayiner, A; Coskun, AS; Durmaz, F; Cilli, A; Celenk, B; Kilinc, O; Salman, S; Hazar, A; Tokgoz, FObjective We aimed to investigate the effect of inhaled corticosteroids (ICS) in the outcomes of community-acquired pneumonia (CAP), as well as to determine if ICS usage is exist among the risk factors for mortality in those patients. Materials and Methods In this retrospective cross-sectional multicentre study, 1069 hospitalised CAP patients were investigated using CAP Database of Turkish Thoracic Society (TURKCAP Database). The patients were divided into two groups, depending on their ICS use. The data were analysed by appropriate statistical methods. Results 172 (75.8%) of the 227 patients who were on ICS had COPD and 37 (16.3%) had asthma. There were fewer patients with fever among ICS-users compared to non-ICS users (P = 0.013), and less muscle pain (P = 0.015) and fewer GIS symptoms (P = 0.022). No statistically significant difference was found between ICS use/ type of ICS and the duration of hospitalisation (P = 0.286). The multivariate regression analysis showed that patients using ICS had lower body temperature and, less crackles/bronchial sound. In the multivariate logistic regression model lung cancer (OR: 6.75), glucose (OR: 1.01) and CURB-65 (OR: 1.72) were significantly associated with mortality in the CAP patients. ICS usage were not found to be associated with mortality. Conclusion The use of ICS by the patients with CAP admitted to the hospital is not independently related with any radiological pattern, hospitalisation duration and mortality. ICS usage may diminish fever response and may suppress the findings of crackles and/or bronchial sounds. This needs further confirmation.Item Comparison Of Four Different Empirical Antibiotic Treatment Regimen For Patients Hospitalized With Community-Acquired PneumoniaCilli, A; Sakar, A; Kilinc, O; Sayiner, A; Hazar, A; Samur, A; Celenk, B; Havlucu, Y; Kilic, O; Tasbakan, S; Kokturk, N; Edis, E; Filiz, A; Uzarslan, EItem CURB 65 or CURB (S) 65 for Community-Acquired Pneumonia?Köktürk, N; Bahecioglu, SN; Baha, A; Gunduz, C; Tasbakan, S; Sayiner, A; Coskun, A; Durmaz, F; Cilli, A; Celenk, B; Kilinc, O; Salman, S; Hazar, A; Tokgoz, FItem Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society databaseBaha, A; Kokturk, N; Bahcecioglu, S; Gunduz, C; Tasbakan, S; Sayiner, A; Coskun, A; Durmaz, F; Cilli, A; Celenk, B; Kilinc, O; Salman, S; Hazar, A; Tokgoz, F